Mr. Yang Liu has 15+ years of strategy and business development experiences in the pharmaceutical industry. He has successfully led or engaged in various types of transactions at different stages and across different therapeutic areas, including nearly 20 collaborations such as strategic investment, M&A, licensing in/out, co-development, and funded research, with increasing responsibilities at Pfizer, Shire, Boehringer Ingelheim and Roche.